Cardio Diagnostics Holdings, Inc's Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/04/23
American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc's Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA CodesBusiness Wire • 11/28/23
Cardio Diagnostics shares rocket on validation of coronary heart disease detection testProactive Investors • 11/20/23
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart AssociationBusiness Wire • 11/20/23
Family Medicine Specialists Selects Cardio Diagnostics' Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield PatientsBusiness Wire • 11/07/23
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHDBusiness Wire • 10/31/23
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to IndiaBusiness Wire • 10/17/23
Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved MarginsBusiness Wire • 10/12/23
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in EpigenomicsBusiness Wire • 09/20/23
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking IndustryBusiness Wire • 09/07/23
Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital's Heart Attack Prevention Clinic on Coronary Artery Disease StudyBusiness Wire • 09/06/23
Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor ConferencesBusiness Wire • 09/05/23
Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic TechnologiesBusiness Wire • 08/18/23
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent ApplicationBusiness Wire • 08/02/23
Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, TexasBusiness Wire • 07/06/23
Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™Business Wire • 06/21/23
Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart DiseaseBusiness Wire • 06/13/23
Cardio Diagnostics Holdings, Inc's Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease ManagementBusiness Wire • 05/16/23
Cardio Diagnostics Holding, Inc's Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease ManagementBusiness Wire • 05/16/23
Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio DiagnosticsBusiness Wire • 05/10/23
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research SystemBusiness Wire • 05/04/23
Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics SolutionBusiness Wire • 04/26/23
Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and EducationBusiness Wire • 04/05/23
